OFD 2024 Bilingual (English / French)

Session Detail

Saturday
Nov 2 2024
Plenary session
BPMH in Ambulatory Oncology Pharmacy Practice
Presenters
Wendy Thompson-McGuire
Steven Riddick
Wendy Thompson-McGuire
North York General Hospital — North York, Ontario

Wendy Thompson-McGuire is a Registered Pharmacy Technician and has over 30 years of experience in various pharmacy areas. This would include community, hospital, education, clinical trials and oncology. 

She currently works as a Oncology and Hematology Drug Access Facilitator at North York General Hospital.  This position enables her to participate in Best Possible Medication History and act as a liaison between the oncology department and our outpatient pharmacy.

Her academic journey includes the University of Toronto and Centennial College.  She enjoys meeting and learning from new individuals entering the world of pharmacy and re-connecting with past pharmacy colleagues.

Wendy Thompson-McGuire
North York General Hospital, North York, Ontario
Steven Riddick
Drug Access Facilitator, North York General Hospital — North York, Ontario

Steven Riddick is a Registered Pharmacy Technician with 13 years of work experience all in the hospital setting.

He is currently employed as an Oncology and Hematology Drug Access Facilitator at North York General Hospital since 2021. Responsibilities include conducting a Best Possible Medication History for new patients and coordinating the coverage of their treatment and supporting medications.

He graduated from Centennial College’s Pharmacy Technician program in 2011.

Steven Riddick
North York General Hospital , North York, Ontario

Presentation Summary
Best Possible Medication Histories (not only a medication list) are incredibly important in ambulatory oncology.  We will review the ISMP guide to BPMH interviewing and share an adapted worksheet that we use to refresh and ensure all attendees understand what a BPMH entails.  BPMHs help identify potential issues such as drug-drug interactions, compliance issues, allergies, etc. before a patient begins anti-cancer therapy.  With input from our ambulatory oncology pharmacists, we will discuss some of the common interactions and concerns identified with the help of a BPMH.  We have conducted an informal survey of a dozen ambulatory oncology clinics in Ontario where we asked who performs a BPMH and when.  We will share the results and discuss the pros and cons of the different health care professionals who are conducting the BPMHs at their respective centers and importance of timing.

Learning Objectives:
1. Review what Medication Reconciliation (MedRec) is and why it is important.
2. Review where the Best Possible Medication History (BPMH) fits into the medication reconciliation process and the steps involved.
3. Understand what organizations support and set the standards for medication reconciliation.
4. Understand why BPMH is important in ambulatory oncology specifically.
5. Identify who conducts a BPMH in ambulatory oncology and when.